title: Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3, 4', 5 tri-hydroxystilbene): molecular mechanisms and therapeutic potential.
abstract: BACKGROUND
  We have previously shown that prostate cancer LNCaP cells are resistant to TRAIL, and downregulation of PI-3K/Akt pathway by molecular and pharmacological means sensitizes cells to undergo apoptosis by TRAIL and curcumin. The purpose of this study was to examine the molecular mechanisms by which resveratrol sensitized TRAIL-resistant LNCaP cells.
  
  
  RESULTS
  Resveratrol inhibited growth and induced apoptosis in androgen-dependent LNCaP cells, but had no effect on normal human prostate epithelial cells. Resveratrol upregulated the expression of Bax, Bak, PUMA, Noxa, Bim, TRAIL-R1/DR4 and TRAIL-R2/DR5, and downregulated the expression of Bcl-2, Bcl-XL, survivin and XIAP. Treatment of LNCaP cells with resveratrol resulted in generation of reactive oxygen species, translocation of Bax and p53 to mitochondria, subsequent drop in mitochondrial membrane potential, release of mitochondrial proteins (cytochrome c, AIF, Smac/DIABLO and Omi/HtrA2), activation of caspase-3 and caspase-9 and induction of apoptosis. The ability of resveratrol to sensitize TRAIL-resistant LNCaP cells was inhibited by dominant negative FADD, caspase-8 siRNA or N-acetyl cysteine. Smac siRNA inhibited resveratrol-induced apoptosis, whereas Smac N7 peptide induced apoptosis and enhanced the effectiveness of resveratrol.
  
  
  CONCLUSIONS
  Resveratrol either alone or in combination with TRAIL or Smac can be used for the prevention and/or treatment of human prostate cancer.
authors: Department of Biochemistry, University of Texas Health Science Center at Tyler, Tyler, Texas, USA 75703. rakeh.srivastava@uthct.edu.
authors: Sharmila
authors: S
authors: Shankar
authors: Qinghe
authors: Q
authors: Chen
authors: Imtiaz
authors: I
authors: Siddiqui
authors: Krishna
authors: K
authors: Sarva
authors: Rakesh K
authors: RK
authors: Srivastava
references: Annu Rev Med. 2006;57:49-63
references: 16409136
references: Cancer Res. 2001 Oct 15;61(20):7456-63
references: 11606380
references: Nature. 1997 Sep 18;389(6648):300-5
references: 9305847
references: Pathophysiology. 2000 Sep;7(3):153-163
references: 10996508
references: Science. 1997 Apr 4;276(5309):111-3
references: 9082980
references: J Exp Med. 1999 Jul 19;190(2):253-65
references: 10432288
references: Science. 1997 Aug 8;277(5327):818-21
references: 9242611
references: Biochim Biophys Acta. 2002 Mar 14;1602(1):47-59
references: 11960694
references: J Clin Oncol. 2005 Nov 10;23(32):8152-60
references: 16278466
references: J Biol Chem. 2003 Aug 22;278(34):31469-72
references: 12835328
references: Nat Med. 1997 Jun;3(6):614-20
references: 9176486
references: EMBO J. 1999 Nov 1;18(21):6027-36
references: 10545114
references: Int J Mol Med. 2005 Dec;16(6):1125-38
references: 16273296
references: Cancer Res. 2003 Apr 1;63(7):1712-21
references: 12670926
references: J Biol Chem. 2005 Jan 21;280(3):2266-74
references: 15537572
references: Nat Med. 2005 Jul;11(7):725-30
references: 16015365
references: Cell. 2005 Jan 14;120(1):7-10
references: 15652475
references: Biochem Soc Symp. 1999;66:1-15
references: 10989652
references: Cancer Res. 2003 Sep 1;63(17):5390-400
references: 14500373
references: Oncogene. 2005 Jul 7;24(29):4609-23
references: 15897906
references: Neoplasia. 2001 Nov-Dec;3(6):535-46
references: 11774036
references: In Vivo. 2005 Jan-Feb;19(1):37-60
references: 15796155
references: Mol Cell Biol. 2003 Dec;23(23):8576-85
references: 14612402
references: Cell Mol Life Sci. 1999 Jan;55(1):9-11
references: 10065147
references: Curr Biol. 1997 Dec 1;7(12):R750-3
references: 9382834
references: J Immunol. 1998 Sep 15;161(6):2833-40
references: 9743343
references: Science. 2004 Jul 30;305(5684):626-9
references: 15286356
references: Nat Cell Biol. 2004 May;6(5):443-50
references: 15077116
references: Oncogene. 2001 Sep 20;20(42):6073-83
references: 11593415
references: Oncogene. 2000 Aug 10;19(34):3840-8
references: 10951577
references: J Biol Chem. 2000 May 26;275(21):16202-12
references: 10821866
references: Carcinogenesis. 2007 Jun;28(6):1277-86
references: 17277231
references: Oncogene. 2001 Apr 19;20(17):2122-33
references: 11360196
references: Biochemistry. 1991 May 7;30(18):4480-6
references: 2021638
references: J Exp Med. 1997 Oct 6;186(7):1165-70
references: 9314565
references: EMBO J. 1997 Sep 1;16(17):5386-97
references: 9311998
references: J Clin Invest. 2005 Oct;115(10):2640-7
references: 16200197
references: Genes Dev. 1999 Feb 1;13(3):239-52
references: 9990849
references: Science. 1991 Jul 5;253(5015):49-53
references: 1905840
references: Nat Rev Cancer. 2002 Aug;2(8):594-604
references: 12154352
references: Science. 2004 Feb 13;303(5660):1010-4
references: 14963330
references: Cancer Lett. 2006 Jan 8;231(1):113-22
references: 16356836
references: Mol Cell. 2003 Mar;11(3):577-90
references: 12667443
references: Science. 1997 Jan 10;275(5297):218-20
references: 8985016
references: Cell. 2005 Jun 3;121(5):671-4
references: 15935754
references: Cancer Res. 2006 Mar 15;66(6):3126-36
references: 16540663
references: Mol Cell Biochem. 2007 Oct;304(1-2):273-85
references: 17636462
references: Cancer Metastasis Rev. 2002;21(2):111-24
references: 12465750
references: Int J Oncol. 2004 May;24(5):1133-40
references: 15067334
references: J Clin Invest. 1999 Jul;104(2):155-62
references: 10411544
references: J Urol. 1999 Jan;161(1):152-5
references: 10037388
references: Curr Biol. 1997 Dec 1;7(12):1003-6
references: 9382840
references: Prostate. 2004 Sep 15;61(1):35-49
references: 15287092
references: Mol Cell Biol Res Commun. 2000 Aug;4(2):67-75
references: 11170835
references: Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S105-14
references: 14508087
references: Nat Med. 1999 Feb;5(2):157-63
references: 9930862
references: Drug Resist Updat. 2004 Apr;7(2):139-56
references: 15158769
references: Nat Rev Cancer. 2002 Sep;2(9):647-56
references: 12209154
references: Genes Dev. 1996 Nov 15;10(22):2859-69
references: 8918887
references: Int J Oncol. 2007 Apr;30(4):905-18
references: 17332930
references: Nat Rev Cancer. 2004 Oct;4(10):793-805
references: 15510160
references: Immunity. 1997 Dec;7(6):813-20
references: 9430226
references: Mol Cell Biol. 1999 Aug;19(8):5659-74
references: 10409755
references: Cancer Res. 2003 Mar 1;63(5):1059-66
references: 12615723
references: Immunol Today. 1997 Jan;18(1):44-51
references: 9018974
references: Cancer Res. 2002 Sep 1;62(17):4929-37
references: 12208743
references: Int J Oncol. 2003 Jan;22(1):5-13
references: 12469179
references: Prostate. 2005 Feb 1;62(2):165-86
references: 15389801
references: Science. 1998 Aug 28;281(5381):1305-8
references: 9721089